HK1080754A1 - Malaria vaccine - Google Patents
Malaria vaccineInfo
- Publication number
- HK1080754A1 HK1080754A1 HK06102595.9A HK06102595A HK1080754A1 HK 1080754 A1 HK1080754 A1 HK 1080754A1 HK 06102595 A HK06102595 A HK 06102595A HK 1080754 A1 HK1080754 A1 HK 1080754A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- protein
- hybrid
- glutamate
- antibody response
- individual
- Prior art date
Links
- 229940124735 malaria vaccine Drugs 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 2
- 102000018697 Membrane Proteins Human genes 0.000 abstract 2
- 108010052285 Membrane Proteins Proteins 0.000 abstract 2
- 230000005875 antibody response Effects 0.000 abstract 2
- 229930195712 glutamate Natural products 0.000 abstract 2
- 210000003936 merozoite Anatomy 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 241000194035 Lactococcus lactis Species 0.000 abstract 1
- 241000224016 Plasmodium Species 0.000 abstract 1
- 241000223960 Plasmodium falciparum Species 0.000 abstract 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
- 235000014897 Streptococcus lactis Nutrition 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 201000004792 malaria Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 108020001775 protein parts Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Transplantation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK200201741A DK200201741A (da) | 2002-11-12 | 2002-11-12 | Vaccine comprising chimeric malaria proteins derived from Plasmodium falciparum |
| DKPA200301307 | 2003-09-11 | ||
| PCT/DK2003/000759 WO2004043488A1 (en) | 2002-11-12 | 2003-11-06 | Malaria vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1080754A1 true HK1080754A1 (en) | 2006-05-04 |
Family
ID=32313776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK06102595.9A HK1080754A1 (en) | 2002-11-12 | 2006-02-27 | Malaria vaccine |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7749507B2 (de) |
| EP (1) | EP1567189B1 (de) |
| JP (1) | JP4573773B2 (de) |
| CN (1) | CN1741815B (de) |
| AT (1) | ATE432081T1 (de) |
| AU (1) | AU2003275949B2 (de) |
| BR (1) | BR0315205A (de) |
| CA (1) | CA2505724C (de) |
| DE (1) | DE60327801D1 (de) |
| DK (2) | DK200201741A (de) |
| ES (1) | ES2326415T3 (de) |
| HK (1) | HK1080754A1 (de) |
| WO (1) | WO2004043488A1 (de) |
| ZA (1) | ZA200504415B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030161840A1 (en) * | 1992-10-19 | 2003-08-28 | Institut Pasteur | Plasmodium falciparum antigens inducing protective antibodies |
| FR2697022B1 (fr) * | 1992-10-19 | 1994-12-16 | Pasteur Institut | Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination. |
| DK200201741A (da) * | 2002-11-12 | 2003-09-16 | Statens Seruminstitut | Vaccine comprising chimeric malaria proteins derived from Plasmodium falciparum |
| US20050112133A1 (en) * | 2003-10-24 | 2005-05-26 | Pierre Druilhe | GLURP-MSP3 fusion protein, immunogenic compositions and malarial vaccines containing it |
| US7488489B2 (en) * | 2004-08-03 | 2009-02-10 | Institut Pasteur | Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies |
| EP2818175B1 (de) * | 2009-05-05 | 2018-11-21 | Cadila Healthcare Limited | Kombinierter Impfstoff gegen Masern und Malaria |
| BR112012001061B8 (pt) | 2009-07-15 | 2021-05-25 | Univ British Columbia | glicosídeos 2,3-fluorados como inibidores de neuraminidase, seu método de preparação, composição farmacêutica que os compreende e embalagem comercial |
| EP2385107B1 (de) | 2010-05-03 | 2016-08-24 | Institut Pasteur | Auf Lentivirusvektor basierende immunologische Verbindungen gegen Malaria |
| DK2763694T3 (en) * | 2011-10-04 | 2018-04-16 | Statens Seruminstitut | Preparation of a cysteine-rich protein |
| US20140348870A1 (en) * | 2011-11-30 | 2014-11-27 | The Regents Of The University Of California | Immunogenic plasmodium falciparum antigen compositions and uses thereof |
| CN102533677B (zh) * | 2012-01-10 | 2013-07-24 | 特菲(天津)生物医药科技有限公司 | 一种疟疾疫苗及其制备方法 |
| WO2013106937A1 (en) | 2012-01-19 | 2013-07-25 | The University Of British Columbia | 3' equatorial-fluorine-substituted neuraminidase inhibitor compounds, compositions and methods for the use thereof as anti-virals |
| CN105652009B (zh) * | 2014-11-11 | 2018-04-24 | 中国科学院苏州纳米技术与纳米仿生研究所 | 可用于辅助诊断疟疾的试剂盒 |
| CN105628928A (zh) * | 2014-11-11 | 2016-06-01 | 深圳国际旅行卫生保健中心 | 可用于辅助诊断疟疾的试剂盒 |
| CA3031399A1 (en) * | 2016-07-21 | 2018-01-25 | Vac4All Pte. Ltd. | Biofusion proteins as anti-malaria vaccines |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5231168A (en) * | 1988-09-16 | 1993-07-27 | Statens Seruminstitut | Malaria antigen |
| DK519188D0 (da) * | 1988-09-16 | 1988-09-16 | Statens Seruminstitut | Kemisk forbindelse |
| AU645482B2 (en) * | 1988-09-16 | 1994-01-20 | Statens Serum Institut | A malaria antigen |
| FR2697022B1 (fr) * | 1992-10-19 | 1994-12-16 | Pasteur Institut | Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination. |
| CA2363118A1 (en) * | 1999-02-25 | 2000-08-31 | Smithkline Beecham Biologicals S.A. | Immunogens comprising a peptide and a carrier derived from h.influenzae protein d |
| EP1390401A2 (de) * | 2001-05-16 | 2004-02-25 | Institut Pasteur | Antigene von plasmodium falciparum und ihre verwendung als impfstoff und zur diagnose |
| DK200201741A (da) * | 2002-11-12 | 2003-09-16 | Statens Seruminstitut | Vaccine comprising chimeric malaria proteins derived from Plasmodium falciparum |
-
2002
- 2002-11-12 DK DK200201741A patent/DK200201741A/da not_active Application Discontinuation
-
2003
- 2003-11-06 BR BR0315205-7A patent/BR0315205A/pt not_active IP Right Cessation
- 2003-11-06 DK DK03810941T patent/DK1567189T3/da active
- 2003-11-06 DE DE60327801T patent/DE60327801D1/de not_active Expired - Lifetime
- 2003-11-06 AT AT03810941T patent/ATE432081T1/de not_active IP Right Cessation
- 2003-11-06 AU AU2003275949A patent/AU2003275949B2/en not_active Expired
- 2003-11-06 WO PCT/DK2003/000759 patent/WO2004043488A1/en active Application Filing
- 2003-11-06 EP EP03810941A patent/EP1567189B1/de not_active Expired - Lifetime
- 2003-11-06 JP JP2005506641A patent/JP4573773B2/ja not_active Expired - Fee Related
- 2003-11-06 ES ES03810941T patent/ES2326415T3/es not_active Expired - Lifetime
- 2003-11-06 CN CN2003801031543A patent/CN1741815B/zh not_active Expired - Lifetime
- 2003-11-06 CA CA2505724A patent/CA2505724C/en not_active Expired - Lifetime
-
2005
- 2005-05-12 US US11/128,660 patent/US7749507B2/en active Active
-
2006
- 2006-01-17 ZA ZA200504415A patent/ZA200504415B/en unknown
- 2006-02-27 HK HK06102595.9A patent/HK1080754A1/xx not_active IP Right Cessation
-
2010
- 2010-06-03 US US12/793,575 patent/US20110020387A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006512926A (ja) | 2006-04-20 |
| WO2004043488A1 (en) | 2004-05-27 |
| ZA200504415B (en) | 2006-03-29 |
| AU2003275949B2 (en) | 2008-06-05 |
| AU2003275949A1 (en) | 2004-06-03 |
| CN1741815A (zh) | 2006-03-01 |
| EP1567189B1 (de) | 2009-05-27 |
| BR0315205A (pt) | 2005-08-16 |
| DK200201741A (da) | 2003-09-16 |
| ATE432081T1 (de) | 2009-06-15 |
| US7749507B2 (en) | 2010-07-06 |
| JP4573773B2 (ja) | 2010-11-04 |
| EP1567189A1 (de) | 2005-08-31 |
| CN1741815B (zh) | 2010-05-26 |
| DE60327801D1 (de) | 2009-07-09 |
| DK1567189T3 (da) | 2009-09-14 |
| CA2505724C (en) | 2015-06-30 |
| ES2326415T3 (es) | 2009-10-09 |
| US20110020387A1 (en) | 2011-01-27 |
| US20060024324A1 (en) | 2006-02-02 |
| CA2505724A1 (en) | 2004-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1080754A1 (en) | Malaria vaccine | |
| CY1114030T1 (el) | Ομοιογενη παρασκευασματα toy il-29 | |
| ATE309360T1 (de) | Vaskularer endothelialer wachstumsfaktor 2 | |
| EP1536828A4 (de) | Verfahren für die zuführung exogener proteine in das zytosol und verwendungen davon | |
| HUP0101343A3 (en) | Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor | |
| ATE321859T1 (de) | B2microglobulin fusionsproteine und varianten mit hoher affinität | |
| AU1013701A (en) | Modified gp100 and uses thereof | |
| WO2004074486A3 (en) | Fusion proteins of interferon alpha muteins with improved properties | |
| ATE286536T1 (de) | Bindungs domänen von plasmodium vivax und plasmodium falciparum erythrozyten-bindenden proteinen | |
| EP1932915A3 (de) | Materialien und Verfahren im Zusammenhang mit verbesserten Impfstrategien | |
| WO2008086386A3 (en) | Adenoviral vector-based malaria vaccines | |
| WO2003062374A3 (en) | Synthetic genes for malarial proteins and methods of use | |
| ATE214097T1 (de) | Die ansteckung blockierende malariaimpfstoffe | |
| ATE448793T1 (de) | Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens | |
| IL90134A0 (en) | Gene for encoding a human malaria vaccine antigen,malarial vaccines and pharmaceutical compositions | |
| WO2001051511A3 (de) | Rekombinante herstellung von humanen histon 1-subtypen sowie deren verwendung für therapeutische zwecke | |
| DE60216523D1 (de) | Herstellung und verwendung von mit verzweigten aminosäuren angereicherten sojaproteinhydrolysaten | |
| WO2004033705A3 (en) | Viral interferon antagonists and uses therefor | |
| AU2003282159A8 (en) | Chimeric recombinant protein and in vitro diagnosis of hiv | |
| GB0220805D0 (en) | Peptide monomers and protein structures | |
| IL147343A0 (en) | Method for enhancing ran or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids | |
| ATE351917T1 (de) | Verfahren zur synthese von peptiden, peptidmimetika und proteinen | |
| EP1392358A4 (de) | Immunogene tumorantigene: für diese kodierende nukleinsäuren und polypeptide und verfahren zu ihrer verwendung | |
| CA2102624A1 (en) | Transmission-blocking vaccine against malaria | |
| ATE346509T1 (de) | Herstellung und verwendung von mit verzweigten aminosäuren angereicherten sojaproteinhydrolysaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PE | Patent expired |
Effective date: 20231105 |